You have 9 free searches left this month | for more free features.

avelumab

Showing 26 - 50 of 171

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • TILT-123
  • Avelumab
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Avelumab
  • +2 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)

Recruiting
  • Central Nervous System Tumors
  • Saint Louis, Missouri
  • +9 more
Jul 21, 2022

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • Avelumab
  • (no location specified)
Oct 26, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Gyeonggi-do, Korea, Republic of
  • +4 more
Jun 14, 2022

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Avelumab
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Glioblastoma, GBM Trial in New York (Avelumab, MRI-guided LITT therapy)

Completed
  • Glioblastoma
  • GBM
  • Avelumab
  • MRI-guided LITT therapy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 31, 2021

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

SOGUG-AVELUMAB_RWD

Recruiting
  • Metastatic Urothelial Carcinoma
  • Avelumab
  • Vigo, Pontevedra, Spain
  • +21 more
Jan 17, 2023

Penile Cancer, Penile Tumors, Penile Squamous Cell Carcinoma Trial in Besançon (Avelumab)

Recruiting
  • Penile Cancer
  • +2 more
  • Avelumab
  • Besançon, France
    Antoine THIERY VUILLEMIN
Feb 23, 2022

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Avelumab
  • +2 more
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Non Small Cell Lung Cancer Trial in Nijmegen (89Zr-avelumab PET, Avelumab)

Completed
  • Non Small Cell Lung Cancer
  • 89Zr-avelumab PET
  • Avelumab
  • Nijmegen, Netherlands
    Radboud University
Jan 6, 2022

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

Bladder Carcinoma Trial in France (Avelumab, GC)

Terminated
  • Bladder Carcinoma
  • Besançon, France
  • +12 more
Apr 26, 2022

Learn About First-line Avelumab Maintenance in Japanese Locally

Not yet recruiting
  • Urothelial Carcinoma
  • Avelumab
  • Nagoya, Aichi, Japan
  • +14 more
Jul 21, 2022

Malignant Mesothelioma (MPM) Trial in United States (Avelumab, Stereotactic Body Radiation Therapy)

Active, not recruiting
  • Malignant Mesothelioma (MPM)
  • Avelumab
  • Stereotactic Body Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)

Recruiting
  • Penile Cancer
  • +2 more
  • Avelumab
  • Best Supportive Care
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Cancer Trial in Germany (Avelumab)

Completed
  • Cancer
  • Avelumab
  • Halle (Saale), Germany
  • +3 more
Feb 24, 2022

Small Cell Lung Carcinoma Trial in Greece (Avelumab)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Avelumab
  • Chaïdári, Athens, Greece
  • +5 more
Apr 18, 2022

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • Avelumab
  • +6 more
  • (no location specified)
Jul 13, 2023

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Avelumab
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)

Completed
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • Avelumab
  • London, United Kingdom
    University College London Hospital
Oct 1, 2021

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021